Live Breaking News & Updates on Ductal carcinoma in situ

Stay informed with the latest breaking news from Ductal carcinoma in situ on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Ductal carcinoma in situ and stay connected to the pulse of your community

Community rallies to support local breast cancer fighter at fundraiser

Sunday a fundraising event was held at Mia Via Restaurant and Bar in Luzerne for Courtney Keezer who was diagnosed with Stage 2 Invasive Ductal Carcinoma, a for

Courtney-keezer , Tracy-myers , Luzerne-co , Mia-via-restaurant , Ductal-carcinoma , Breast-cancer , Health-medical-pharma , Cancer , Hereditary-cancers , Breast-cancer-awareness , Breast-surgery , Mastectomy

Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update

Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New-york , United-states , Australia , American , Australian , Matthew-goetz , Eric-van-zanten , Jonathan-finn , Tessa-cigler , Weill-cornell-breast-center , Exchange-commission , Australian-taxation-office

Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update

Fully enrolled two Phase 2 studies with data from both expected in the second half of 2024First patient dosed in new Phase 2 breast cancer prevention studyData from ongoing Phase

United-states , Australia , New-york , American , Australian , Jonathan-finn , Tessa-cigler , Eric-van-zanten , Matthew-goetz , Development-expense , Atossa-therapeutics-inc , Weill-cornell-breast-center

Atossa Therapeutics Announces First Patient Dosing of (Z)-Endoxifen in the Ongoing RECAST DCIS Study

SEATTLE, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative proprietary medicines to address significant unmet needs in oncology with a focus on breast cancer, today announced that the first patient has been dosed with Atossa’s proprietary Selective Estrogen Receptor Modulator (SERM), (Z)-endoxifen, in the Re-Evaluating Conditions for Active Surveillance Suitability as Treatment: Ductal Carcinoma In Situ (R

California , United-states , San-francisco , Eric-van-zanten , Nasdaq , University-of-california , Atossa-therapeutics-inc , Selective-estrogen-receptor-modulator , Re-evaluating-conditions , Active-surveillance-suitability , Ductal-carcinoma-in-situ , Carcinoma-in-situ

Atossa Therapeutics doses first patient with (Z)-endoxifen in Phase 2 breast cancer trial

Atossa Therapeutics doses first patient with (Z)-endoxifen in Phase 2 breast cancer trial
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Atossa-therapeutics-inc , Re-evaluating-conditions , Active-surveillance-suitability , Ductal-carcinoma-in-situ , Steven-quay ,

Exact Sciences: Growing Revenue With An Innovative Approach To Oncology (NASDAQ:EXAS)

Exact Sciences: Growing Revenue With An Innovative Approach To Oncology (NASDAQ:EXAS)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Precision-oncology , Exact-sciences , Exact-science , Breast-recurrence-score , Colon-recurrence-score , San-antonio-breast-cancer-symposium , Resonance-imaging , Gene-expression-assay , Optimize-local-therapy , Ductal-carcinoma-in-situ , Late-breaking-abstract

Atossa Therapeutics Issues Letter to Shareholders

SEATTLE, Jan. 09, 2024 -- Atossa Therapeutics, Inc. , a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus...

United-states , California , San-francisco , Eric-van-zanten , Matthew-goetz , Weill-cornell , Nasdaq , Exchange-commission , Mayo-clinic-comprehensive-cancer-center , Globenewswire-inc , University-of-california , Breast-cancer-research-foundation

Study Finds Associations Between T Cell Diversity in Peripheral Blood and Patient Age, Stage of Breast Cancer Development

Researchers at Dana-Farber Cancer Institute found that the diversity of T cells in peripheral blood declines with age in patients with breast cancer and, in younger patients, is lower in those diagnosed with metastatic disease than with ductal carcinoma in situ.

United-states , American , Susang-komen , Jun-nishida , Kornelia-polyak , Simona-cristea , Franziska-michor , Dana-farber-ann-partridge , Nancy-lin , Sudheshna-bodapati , American-cancer-society , National-cancer-institute

Oncotype Score Helps Avoid Unnecessary Radiation in DCIS

Using a gene test to guide radiation decisions may reduce overtreatment in ductal carcinoma in situ.

Northwestern-university , Illinois , United-states , Chicago , San-antonio , Texas , Seema-khan , Ut-health-san-antonio , Antonio-breast-cancer , Breast-cancer , Alignant-breast-neoplasm , Reast-carcinoma

Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer Patients

Updated TAILORx follow-up data showing the integration of clinico-pathologic criteria and Recurrence Score® results to refine distant recurrence risk estimates...

Puerto-rico , United-states , Ireland , United-kingdom , Switzerland , Nottingham , Irish , Swiss , Puerto-rican , Irish-national-analysis-of-the-clinical , Magnetic-resonance-imaging